, South Korea
/JW Ju from Unsplash

Hanwha General should bolster its digital non-life subsidiary

HGI reported a consolidated ROE of 6.5% in 2023.

Hanwha General Insurance’s (HGI) ongoing initiatives are seen to improve profitability and scale the operations of its digital non-life subsidiary, Carrot General Insurance Company Limited, AM Best said.

HGI’s risk-adjusted capitalisation, measured by Best’s Capital Adequacy Ratio (BCAR), is assessed at the strongest level. 

The company's capital and surplus saw a significant increase at the end of 2023 under the IFRS 17 accounting standard, though this did not materially affect its balance sheet fundamentals. HGI maintains solid asset-liability management and strong financial flexibility, with wide access to capital markets.

In 2023, HGI reported a consolidated return on equity of 6.5% and a combined ratio of 95.9% under IFRS 17. Its long-term insurance profitability remained stable, with past rate hikes on legacy medical indemnity policies contributing to this stability. 

HGI is the sixth-largest non-life insurer in South Korea, holding a market share of approximately 6% in insurance service revenue in 2023, with a focus on long-term insurance. The rating also considers the implicit and explicit support from Hanwha Life, including co-branding, product distribution, and capital support.

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.